|
- Latest news - Johnson Johnson
A collection of stories that highlight the way Johnson Johnson is making an impact in the lives of its consumers, and the latest press releases from the company
- Real World Evidence Shows Johnson Johnson COVID-19 Vaccine . . .
NEW BRUNSWICK, N J , January 6, 2022 – Johnson Johnson (NYSE: JNJ) (the Company) today announced new results from the largest study to date on the durability of COVID-19 vaccines in the United States (U S ), showing that a single shot of the Johnson Johnson COVID-19 vaccine resulted in long-lasting protection for up to six months against
- News | Johnson Johnson - Investors
You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson Johnson Services, Inc Contact us with any questions or search this site for more information
- Press Releases - Johnson Johnson
Explore all Johnson Johnson published press releases by date and or topic of news
- Oncology latest news - Johnson Johnson
Johnson Johnson’s DARZALEX® (daratumumab) subcutaneous-based regimen receives positive CHMP opinion for patients with newly diagnosed multiple myeloma, regardless of transplant eligibility
- Positive New Data for Johnson Johnson Single-Shot COVID-19 Vaccine on . . .
NEW BRUNSWICK, N J , July 1, 2021 – Johnson Johnson (NYSE: JNJ) (the Company) today announced data that demonstrated its single-shot COVID-19 vaccine generated strong, persistent activity against the rapidly spreading Delta variant and other highly prevalent SARS-CoV-2 viral variants In addition, the data showed that the durability of the
- Latest COVID-19 News - Johnson Johnson
Latest news and press releases on Johnson Johnson’s efforts to stem the COVID-19 pandemic
- Johnson Johnson’s 2025 first-quarter earnings are here
What you need to know about Johnson Johnson’s 2025 first-quarter earnings Here’s an infographic breakdown of the company’s first-quarter earnings results, including highlights from its Innovative Medicine and MedTech businesses
|
|
|